Regeneron Pharmaceuticals (REGN) FY Conference June 09, 2025 10:40 AM ET Speaker0 Morning, everyone. Thank you for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. I'm really pleased to be joined by the Regeneron team. Next to me is Chris Feinmore, Head of Finance and CFO and Ryan Crow, Head of IR and Strategic Analysis. So to start here, actually, Ryan, let me turn it over to you because I think you have some opening comments. Speaker1 Yeah, just some forward looking statement busin ...